| Strong improvement of EBITA margin before restructuring and acquisition-related charges and a EUR 87 million provision release | |
| Comparable sales down 11%, mainly attributable to Consumer Lifestyle and Lighting, up from the 19% decline visible in the second quarter | |
| Double-digit growth in emerging markets for Healthcare not fully offsetting declines in the US | |
| Restructuring and acquisition-related charges of EUR 125 million reflect ongoing reduction of our cost base | |
| Free cash flow of EUR 353 million exceeded EBITA in the quarter |
Gerard Kleisterlee, President and CEO of Royal Philips Electronics: |
All amounts in millions of euros unless otherwise stated; data included are unaudited. Financial reporting is in accordance with IFRS, unless otherwise stated. This document comprises regulated information within the meaning of the Dutch Financial Markets Supervision Act Wet op het Financieel Toezicht. |
2
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Sales |
6,334 | 5,621 | ||||||
EBITA |
57 | 344 | ||||||
as a % of sales |
0.9 | 6.1 | ||||||
EBIT |
(133) | 237 | ||||||
as a % of sales |
(2.1) | 4.2 | ||||||
Financial income and expenses |
158 | (44) | ||||||
Income taxes |
3 | (56) | ||||||
Results equity-accounted investees |
9 | 39 | ||||||
Income (loss) from continuing operations |
37 | 176 | ||||||
Discontinued operations |
21 | - | ||||||
Net income (loss) |
58 | 176 | ||||||
Attribution of net income (loss) |
||||||||
Net income
(loss) - stockholders |
57 | 174 | ||||||
Net income - minority interests |
1 | 2 | ||||||
Net income
(loss) - stockholders |
||||||||
per common
share (in euros) - basic |
0.06 | 0.19 | ||||||
Q3 | Q3 | % change | ||||||||||||||
2008 | 2009 | nominal | compa- | |||||||||||||
rable | ||||||||||||||||
Healthcare |
1,806 | 1,821 | 1 | (4) | ||||||||||||
Consumer Lifestyle |
2,578 | 2,073 | (20) | (15) | ||||||||||||
Lighting |
1,846 | 1,646 | (11) | (13) | ||||||||||||
GM&S |
104 | 81 | (22) | (24) | ||||||||||||
Philips Group |
6,334 | 5,621 | (11) | (11) |
Net income | ||
| Income from continuing operations increased by EUR 139 million year-on-year, driven by higher earnings and lower net charges. | |
| Income included a gain of EUR 87 million related to a release of a provision for retiree medical benefits, EUR 125 million of restructuring and acquisition-related charges, and a EUR 30 million partial reversal of last years TPV impairment loss. | |
| In Q3 2008, income included a EUR 342 million financial gain on the sale of TSMC shares, which was more than offset by a EUR 259 million asbestos-related settlement charge, EUR 74 million of restructuring and acquisition-related charges, and EUR 189 million in impairment losses at LG Display and Toppoly. |
Sales by sector | ||
| Sales amounted to EUR 5,621 million, representing a decline of 11% on both a nominal and comparable basis. A positive currency impact of 2% was offset by portfolio changes. | |
| Healthcare sales declined by 4% on a comparable basis, as growth at Customer Services and Home Healthcare Solutions was more than offset by declines at Clinical Care Systems, Imaging Systems and Healthcare Informatics. | |
| Consumer Lifestyle sales fell by 15% on a comparable basis, due to sales declines in all businesses except Health & Wellness. | |
| Lighting sales declined by 13% on a comparable basis, led by double-digit declines at Professional Luminaires, Lighting Electronics and Automotive Lighting. |
3
Q3 | Q3 | % change | |||||||||||||||
2008 | 2009 | nominal | compa- | ||||||||||||||
rable | |||||||||||||||||
Western Europe |
2,117 | 1,974 | (7) | (6) | |||||||||||||
North America |
1,844 | 1,583 | (14) | (16) | |||||||||||||
Other mature markets |
311 | 302 | (3) | (9) | |||||||||||||
Total mature markets |
4,272 | 3,859 | (10) | (11) | |||||||||||||
Emerging markets |
2,062 | 1,762 | (15) | (11) | |||||||||||||
Philips Group |
6,334 | 5,621 | (11) | (11) |
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Healthcare |
188 | 175 | ||||||
Consumer Lifestyle |
63 | 129 | ||||||
Lighting |
183 | 79 | ||||||
Group Management & Services |
(377) | (39) | ||||||
Philips Group |
57 | 344 | ||||||
as a % of sales |
0.9 | 6.1 | ||||||
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Healthcare |
10.4 | 9.6 | ||||||
Consumer Lifestyle |
2.4 | 6.2 | ||||||
Lighting |
9.9 | 4.8 | ||||||
Group Management & Services |
(362.5) | (48.1) | ||||||
Philips Group |
0.9 | 6.1 |
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Healthcare |
(17) | (40) | ||||||
Consumer Lifestyle |
(46) | (29) | ||||||
Lighting |
(11) | (42) | ||||||
Group Management & Services |
- | (14) | ||||||
Philips Group |
(74) | (125) |
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Healthcare |
129 | 110 | ||||||
Consumer Lifestyle |
59 | 126 | ||||||
Lighting |
56 | 40 | ||||||
Group Management & Services |
(377) | (39) | ||||||
Philips Group |
(133) | 237 | ||||||
as a % of sales |
(2.1) | 4.2 |
| In mature markets, double-digit declines at Lighting and Consumer Lifestyle were partially offset by a mid-single-digit decline at Healthcare. | |
| While sales in the emerging markets showed considerable sequential improvement, they remained 11% below Q3 2008 on a comparable basis. Consumer Lifestyle saw a double-digit sales decline, particularly in Latin America and Russia. While Lighting sales in emerging markets saw a single-digit decline, in China and India they continued to grow. These declines were partially offset by double-digit growth at Healthcare in nearly all emerging markets. |
| EBITA increased by EUR 287 million compared to Q3 2008, favorably impacted by a EUR 87 million release of a provision for retiree medical benefits and last years EUR 259 million asbestos-related charge, partly offset by a EUR 51 million increase in restructuring and acquisition-related charges. | |
| EBIT increased by EUR 370 million compared to Q3 2008, a quarter which also included a goodwill impairment of EUR 90 million at Lumileds. | |
| Healthcare EBITA saw a slight year-on-year decline as Q3 2008 included a EUR 45 million divestment gain. Excluding this gain and restructuring and acquisition-related charges, EBITA improved by EUR 55 million to EUR 215 million (11.8% of sales), thanks to improvements in most businesses, notably Customer Services. | |
| Consumer Lifestyle EBITA was EUR 129 million, or 6.2% of sales, a year-on-year increase of EUR 66 million driven by higher earnings in most businesses. Excluding restructuring and acquisition-related charges, Television was close to break-even, which helped take the overall sector EBITA before charges to EUR 49 million above the level of Q3 2008. | |
| Lighting EBITA was EUR 104 million lower than in Q3 2008 due to lower operational earnings, mainly at Lamps and Professional Luminaires, and higher restructuring and acquisition-related charges. Excluding these charges, EBITA was EUR 73 million lower year-on-year. | |
| GM&S EBITA improved by EUR 338 million compared to Q3 2008, a quarter which included EUR 259 million asbestos-related charges. The current quarter included a EUR 87 million release of a provision for retiree medical benefits. |
4
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Net interest expenses |
(19) | (61) | ||||||
TSMC |
||||||||
Sale of securities |
342 | - | ||||||
Dividend |
23 | - | ||||||
LG Display impairment |
(178) | - | ||||||
Toppoly impairment |
(11) | - | ||||||
TPV option fair-value adjustment |
(20) | 18 | ||||||
Other |
21 | (1) | ||||||
158 | (44) |
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
TPV value adjustment |
- | 30 | ||||||
Other |
9 | 9 | ||||||
9 | 39 |
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Cash of continuing operations |
2,396 | 3,589 | ||||||
Cash of discontinued operations |
94 | - | ||||||
Beginning balance |
2,490 | 3,589 | ||||||
Free cash flow |
57 | 353 | ||||||
Net cash from operating activities |
210 | 470 | ||||||
Net capital expenditures |
(153) | (117) | ||||||
Acquisitions (divestments) |
14 | (172) | ||||||
Other cash from investing activities |
776 | (36) | ||||||
(Repurchase) delivery of shares |
(803) | 6 | ||||||
Changes in debt/other |
(56) | (6) | ||||||
Net cash flow discontinued operations |
(18) | - | ||||||
Ending balance |
2,460 | 3,734 | ||||||
Less cash of discontinued operations |
- | - | ||||||
Cash of continuing operations |
2,460 | 3,734 |
| Net interest expenses increased compared to Q3 2008 as a result of lower interest rates on deposits and higher interest costs on derivatives related to hedging of foreign-currency funding positions. | |
| Q3 2008 included a EUR 342 million gain on the sale of the remaining stake in TSMC as well as dividend income from TSMC of EUR 23 million. | |
| Also in Q3 2008, impairment losses of EUR 178 million and EUR 11 million were reported for LG Display and Toppoly respectively. |
| A EUR 30 million gain was recorded due to the partial reversal of a EUR 59 million TPV impairment loss recognized in December 2008. |
| The Group cash balance increased by EUR 145 million to EUR 3.7 billion, driven by free cash inflow of EUR 353 million, partly offset by EUR 172 million in payments for acquisitions, mainly the Saeco espresso business. | |
| In Q3 2008 the cash balance declined slightly as proceeds from the sale of stakes (EUR 688 million, mainly TSMC), cash from derivatives (EUR 88 million) and free cash inflow (EUR 57 million) were more than offset by share buy-back (EUR 803 million) and short-term debt repayment (EUR 98 million). |
5
| Operating activities generated a cash inflow of EUR 470 million, compared to an inflow of EUR 210 million in Q3 2008. The increase of EUR 260 million was driven by higher cash earnings and lower working capital requirements. |
| Gross capital expenditures on property, plant and equipment were EUR 67 million lower than in Q3 2008, primarily due to lower investments at Lighting and Healthcare. |
| Inventories as a percentage of sales rose by 0.7 percentage points to 14.0% at the end of the quarter, with modest improvements at Lighting and Healthcare more than offset by an increase at Consumer Lifestyle. The ratio was 1.1 percentage points below the level of Q3 2008, due to lower inventory levels at Healthcare and Lighting. | |
| In value, inventories saw a slight sequential increase as the additional inventory from the acquisition of Saeco was only partly offset by lower inventories at Lighting and Healthcare. Compared to Q3 2008, inventories decreased by EUR 796 million, mainly at Consumer Lifestyle and Lighting. |
6
in billions of euros
|
group equity | net debt |
| At the end of the quarter the net debt position amounted to EUR 0.6 billion, compared to EUR 1.5 billion at the end of Q3 2008. During the quarter, the net debt position decreased by EUR 219 million, mainly due to EUR 353 million free cash flow, partly offset by a EUR 169 million cash payment for Saeco. | |
| Group equity remained stable in the quarter at EUR 13.4 billion. |
| The increase in the number of employees was largely attributable to a seasonality-driven increase in temporary labor. The additional headcount related to the acquisition of Saeco was offset by a reduction in permanent employees elsewhere across the Company. | |
| Compared to Q3 2008, the number of employees decreased by 9,786, primarily at Lighting (down 8,431) and Healthcare (down 1,091). |
7
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Sales |
1,806 | 1,821 | ||||||
Sales growth |
||||||||
% nominal |
14 | 1 | ||||||
% comparable |
5 | (4) | ||||||
EBITA |
188 | 175 | ||||||
as a % of sales |
10.4 | 9.6 | ||||||
EBIT |
129 | 110 | ||||||
as a % of sales |
7.1 | 6.0 | ||||||
Net operating capital (NOC) |
8,668 | 8,413 | ||||||
Number of employees (FTEs) |
35,841 | 34,750 |
EBITA in millions of euros | EBITA as a % of sales |
| Philips acquired InnerCool Therapies Inc., a pioneer in the field of therapeutic hypothermia, strengthening its position in the emergency care market by adding body temperature management solutions. | |
| Philips received certification in China for the latest addition to its value line of ultrasound systems. Designed specifically for emerging markets, this system is part of the HD family of ultrasound systems, which deliver high-quality imaging in an affordable package to meet the needs of both mature and emerging markets. | |
| Egypts Ministry of Health and Population is equipping approximately 1,000 ambulances with Philips patient monitoring and defibrillation devices. | |
| Philips, in cooperation with Dutch health insurance firm Achmea, announced that Isala hospitals in the Netherlands have started using the Philips Motiva home healthcare system, marking the ninth installation at a Dutch hospital since the launch of Philips Motiva with Achmea in November 2007. |
| Currency-comparable equipment order intake declined 7% year-on-year. The North American market continued to show weakness, mainly affecting Imaging Systems, as the uncertainty around US healthcare reform continued to adversely impact order intake. This decline was partly offset by growth outside North America at Imaging Systems and growth across most businesses in emerging markets. | |
| Comparable sales at Healthcare declined 4% year-on-year. Double-digit growth in emerging markets was offset by declines in the US notably at Imaging Systems, Patient Monitoring and Clinical Care Systems. | |
| EBITA amounted to EUR 215 million, or 11.8% of sales, excluding EUR 40 million of restructuring and acquisition- related charges. The comparable figure in Q3 2008, also excluding a EUR 45 million gain on the sale of Speech Recognition Systems, was EUR 160 million, or 8.9% of sales. EBITA improved at most businesses, notably Customer Services, mainly driven by operational improvement and strict cost management. |
8
| In Q4, restructuring and acquisition-related charges are expected to total around EUR 35 million. | |
| In October, Philips Respironics will launch a new Sleep Therapy System to treat Obstructive Sleep Apnea. Using intelligent technology, this new system simplifies patient management by immediately indicating the potential need for specialized therapy for OSA patients, and is designed for greater patient comfort by making it easier for patients to adapt to therapy. |
9
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Sales |
2,578 | 2,073 | ||||||
of which Television |
1,134 | 767 | ||||||
Sales growth |
||||||||
% nominal |
(19) | (20) | ||||||
% comparable |
(9) | (15) | ||||||
Sales growth excl. Television |
||||||||
% nominal |
(16) | (10) | ||||||
% comparable |
(7) | (12) | ||||||
EBITA |
63 | 129 | ||||||
of which Television |
(73) | (26) | ||||||
as a % of sales |
2.4 | 6.2 | ||||||
EBIT |
59 | 126 | ||||||
of which Television |
(73) | (26) | ||||||
as a % of sales |
2.3 | 6.1 | ||||||
Net operating capital (NOC) |
1,761 | 1,041 | ||||||
of which Television |
157 | (390) | ||||||
Number of employees (FTEs) |
20,662 | 19,569 | ||||||
of which Television |
6,085 | 5,001 |
EBITA in millions of euros | EBITA as a % of sales |
| Philips completed the acquisition of Saeco International Group S.p.A. of Italy, one of the worlds leading espresso machine makers. This move makes Philips a global leader in coffee machines. | |
| Philips showcased its latest consumer-driven innovations at IFA, Europes largest consumer lifestyle trade show. Highlights included a new high-end collection of kitchen appliances, a new range of notebook accessories, and the latest TVs and Blu-ray players. | |
| Philips successfully launched Sonicare For Kids, the first-ever Sonicare power toothbrush for children. This step broadens the Philips Oral Healthcare portfolio. | |
| Philips received two product awards from the European Imaging & Sound Association (EISA), with a model in the high-end TV range named European LCD TV 2009-2010 and the combination of the Philips Cinema 21:9 LCD TV and a Philips Blu-ray Disc player given the European Home Theater Innovation 2009-2010 award. |
| The 20% nominal sales decline includes the impact of proactive portfolio changes, notably at Television and Audio & Video Multimedia. On a comparable basis, sales were 15% below Q3 2008, mainly impacted by double-digit declines at Audio & Video Multimedia, Television, and Peripherals & Accessories. At Domestic Appliances and Shaving & Beauty, sales declines were in the low single-digits, while Health & Wellness showed moderate growth. | |
| EBITA amounted to EUR 129 million, a year-on-year improvement of EUR 66 million. Adjusted for restructuring and acquisition-related charges, EBITA improved from EUR 109 million (4.2% of sales) in Q3 2008 to EUR 158 million (7.6% of sales), with higher earnings in nearly all businesses. Television neared break-even in the quarter due to ongoing improvement actions. | |
| Headcount relative to Q3 2008 showed a slight decrease as the addition of some 2,000 employees following the acquisition of Saeco was more than offset by the effect of portfolio changes and actions taken to rightsize the organization. |
10
| In Q4, Consumer Lifestyle expects to incur a further EUR 40 million of restructuring charges and EUR 10 million of acquisition-related charges. | |
| Providing Chinese consumers with a new way to easily prepare a variety of healthy meals, Philips will launch an innovative rice cooker in Q4. | |
| Saeco will roll out their latest fully automatic coffee machines, which were very well received at IFA in Berlin. The new flagship Xelsis and the compact Syntia will be available throughout Europe. |
11
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Sales |
1,846 | 1,646 | ||||||
Sales growth |
||||||||
% nominal |
19 | (11) | ||||||
% comparable |
6 | (13) | ||||||
EBITA |
183 | 79 | ||||||
as a % of sales |
9.9 | 4.8 | ||||||
EBIT |
56 | 40 | ||||||
as a % of sales |
3.0 | 2.4 | ||||||
Net operating capital (NOC) |
6,458 | 5,382 | ||||||
Number of employees (FTEs) |
60,067 | 51,636 |
EBITA in millions of euros | EBITA as a % of sales |
Business highlights | ||
| Philips was the first company to submit an entry in a competition organized by the US Department of Energy challenging the industry to develop high-quality, LED-based alternatives to 60W incandescent light bulbs. The submitted LED retrofit lamp has clear potential to become a mass-market product. | |
| Philips acquired Teletrol Systems Inc., a leading supplier of integrated solutions for simultaneous multi-site management of lighting and energy usage. This acquisition will strengthen Philips range of sophisticated control solutions. | |
| Philips achieved further success in energy-efficient LED-based outdoor lighting with new installations of street lighting in 30 towns and cities in Portugal, while also supplying LEDs to light up the prestigious International Garden Festival in France. | |
Financial performance | ||
| Comparable sales declined by 13% year-on-year, due to ongoing weakness in many end-markets resulting from the global economic slowdown. Sequentially, however, comparable sales improved in almost all businesses, supported by strong growth in Asian markets. | |
| EBITA amounted to EUR 79 million, or 4.8% of sales. Excluding restructuring and acquisition-related charges, EBITA totaled EUR 121 million, or 7.4% of sales. The comparable figure in Q3 2008 was EUR 194 million, or 10.5% of sales. | |
| Net operating capital decreased by EUR 1.1 billion year-on-year, to EUR 5.4 billion. Working capital requirements declined substantially compared to Q3 2008. | |
Looking ahead | ||
| Restructuring and acquisition-related charges of around EUR 85 million are expected in Q4, targeted at further reduction of fixed costs related to conventional lighting technologies. | |
| In Q4, Philips plans to launch a wide range of new LED-based lighting solutions across many segments, including Outdoor, Retail and Office, while continuing to launch LED retrofit lamps in key markets around the world. |
12
Q3 | Q3 | |||||||
2008 | 2009 | |||||||
Sales |
104 | 81 | ||||||
Sales growth |
||||||||
% nominal |
(29) | (22) | ||||||
% comparable |
(24) | (24) | ||||||
EBITA Corporate Technologies |
(26) | (45) | ||||||
EBITA Corporate & Regional Costs |
(55) | (44) | ||||||
EBITA Pensions |
1 | 76 | ||||||
EBITA Service Units and Other |
(297) | (26) | ||||||
EBITA |
(377) | (39) | ||||||
EBIT |
(377) | (39) | ||||||
Net operating capital (NOC) |
484 | (3,277) | ||||||
Number of employees (FTEs) |
11,441 | 12,270 |
Business highlights | ||
| Philips improved its position in the annual top-100 global brands ranking from Interbrand, moving up one notch to become the 42nd most valuable brand in the world with a total brand value of USD 8.1 billion. | |
| For the 9th year in a row Philips was included in the Dow Jones Sustainability Indexes, which track the sustainability performance of the worlds largest companies, receiving sector leadership status in the category Leisure Goods. | |
| Philips Research continues to join forces to foster innovation in healthcare, partnering with Bruker BioSpin to develop ground-breaking Magnetic Particle Imaging technology for the preclinical market, and with GlyGenix Therapeutics to explore the use of ultrasound technologies in gene therapy. | |
| Philips Design received several design awards including the prestigious INDEX:Award for its innovative, sustainable healthy cooking stove Chulha and a Bronze Industrial Design Excellence Award for the Philips Kitten Scanner. | |
Financial performance | ||
| EBITA amounted to a loss of EUR 39 million, compared to a loss of EUR 377 million in Q3 2008. The year-on-year improvement was driven by a EUR 87 million release of a provision for retiree medical benefits, whereas Q3 2008 included a EUR 259 million asbestos-related charge. Restructuring charges amounted to EUR 14 million. | |
| Net operating capital decreased by EUR 3.8 billion year-on-year, due to pension adjustments in Q4 2008 and Q2 2009. | |
Looking ahead | ||
| Restructuring charges at Group Management & Services are expected to amount to EUR 30 million in Q4, largely related to the realignment of group R&D activities. |
13
| Comparable sales were 16% lower than in the first nine months of 2008, reflecting the impact of the global economic downturn, with declines visible in all sectors, mainly at Consumer Lifestyle (23%) and Lighting (17%). | |
| EBITA amounted to EUR 388 million, 46% lower than in the corresponding period of 2008, primarily due to higher restructuring and acquisition-related charges, offset by a release of a provision for retiree medical benefits; Q3 2008 included the asbestos settlement and net gains on the sale of businesses and real estate. | |
| Compared to the first nine months of 2008, financial income and expenses declined by EUR 0.9 billion to a net expense of EUR 88 million, mainly due to last years gains on the sale of stakes in TSMC (EUR 1.2 billion) and LG Display (EUR 158 million), higher impairment charges for NXP (EUR 251 million) and impairment charges for LG Display (EUR 178 million) and Toppoly (EUR 42 million). | |
| Results relating to equity-accounted investees included the TPV value adjustment (EUR 55 million), whereas last years figure was mainly comprised of operational earnings of LG Display (EUR 66 million). |
January-September | ||||||||
2008 | 2009 | |||||||
Sales |
18,762 | 15,926 | ||||||
EBITA |
718 | 388 | ||||||
as a % of sales |
3.8 | 2.4 | ||||||
EBIT |
357 | 59 | ||||||
as a % of sales |
1.9 | 0.4 | ||||||
Financial income and expenses |
793 | (88) | ||||||
Income tax expense |
(139) | 130 | ||||||
Results equity-accounted investees |
71 | 63 | ||||||
Income (loss) from continuing operations |
1,082 | 164 | ||||||
Discontinued operations |
5 | - | ||||||
Net income (loss) |
1,087 | 164 | ||||||
Attribution of net income (loss) |
||||||||
Net income
(loss) - stockholders |
1,083 | 159 | ||||||
Net income - minority interests |
4 | 5 | ||||||
Net income
(loss) - stockholders |
||||||||
Per common
share (in euros) - basic |
1.07 | 0.17 |
| Sales for the first nine months totaled EUR 15.9 billion, 16% lower than in the corresponding period of 2008 on a comparable basis. The year-to-date share of total sales attributable to emerging markets was 29%, 2 percentage points below last year. Order intake at Healthcare declined 11% compared to the first nine months of 2008. Sales at Healthcare showed a comparable decline of 4% year-on-year, while comparable sales at Consumer Lifestyle declined 23%. Lighting showed a 17% comparable decrease year-on-year. | |
| EBITA in the first nine months of 2009 was EUR 388 million, 46% lower than in the corresponding period of 2008. EBITA includes a release of a provision for retiree medical benefits (EUR 87 million) and higher restructuring and acquisition-related charges (EUR 87 million), whereas last year included EUR 259 million of charges related to the asbestos claim settlement, gains on the sale of the Set-Top Box business (EUR 40 million), the Speech Recognition activity (EUR 45 million) and real estate (EUR 39 million), as well as a loss on the sale of HTP Optics (EUR 13 million). | |
| Net income in the first nine months of 2009 decreased by EUR 0.9 billion compared to the corresponding period of 2008. This reduction is attributable to EUR 298 million lower EBIT and a EUR 0.9 billion decline in financial income, offset by lower income tax expense (EUR 269 million) mainly due to recognition of a deferred tax asset for Lumileds and a number of tax settlements. | |
| Cash flows from operating activities showed an increase of EUR 723 million compared to the first nine months of 2008, resulting from strict management of working capital (in particular inventory levels). | |
| Net operating capital decreased by EUR 5.8 billion compared to the level at the end of Q3 2008, largely due to lower working capital requirements (EUR 5.0 billion), including adjustments to pension assets and liabilities (EUR 3.5 billion). |
14
15
16
3rd quarter | January to September | |||||||||||||||
2008 | 2009 | 2008 | 2009 | |||||||||||||
Sales |
6,334 | 5,621 | 18,762 | 15,926 | ||||||||||||
Cost of sales |
(4,422 | ) | (3,645 | ) | (12,720 | ) | (10,518 | ) | ||||||||
Gross margin |
1,912 | 1,976 | 6,042 | 5,408 | ||||||||||||
Selling expenses |
(1,304 | ) | (1,242 | ) | (3,730 | ) | (3,640 | ) | ||||||||
General and administrative expenses |
(280 | ) | (129 | ) | (763 | ) | (597 | ) | ||||||||
Research and development expenses |
(444 | ) | (372 | ) | (1,250 | ) | (1,161 | ) | ||||||||
Impairment of goodwill |
(90 | ) | - | (90 | ) | - | ||||||||||
Other business income |
97 | 9 | 224 | 73 | ||||||||||||
Other business expenses |
(24 | ) | (5 | ) | (76 | ) | (24 | ) | ||||||||
Income (loss) from operations |
(133 | ) | 237 | 357 | 59 | |||||||||||
Financial income |
421 | 35 | 1,566 | 208 | ||||||||||||
Financial expenses |
(263 | ) | (79 | ) | (773 | ) | (296 | ) | ||||||||
Income (loss) before taxes |
25 | 193 | 1,150 | (29 | ) | |||||||||||
Income taxes |
3 | (56 | ) | (139 | ) | 130 | ||||||||||
Income after taxes |
28 | 137 | 1,011 | 101 | ||||||||||||
Results relating to equity-accounted investees |
9 | 39 | 71 | 63 | ||||||||||||
Income from continuing operations |
37 | 176 | 1,082 | 164 | ||||||||||||
Discontinued operations - net of income taxes |
21 | - | 5 | - | ||||||||||||
Net income for the period |
58 | 176 | 1,087 | 164 | ||||||||||||
Attribution of net income for the period |
||||||||||||||||
Net income attributable to stockholders |
57 | 174 | 1,083 | 159 | ||||||||||||
Net loss attributable to minority interests |
1 | 2 | 4 | 5 | ||||||||||||
Weighted average number of common shares outstanding (after deduction |
||||||||||||||||
of treasury stock) during the period (in thousands): |
||||||||||||||||
basic |
972,087 | 926,461 | 1,010,707 | 925,001 | ||||||||||||
diluted |
977,701 | 930,512 | 1,018,530 | 927,889 | ||||||||||||
Net income attributable to stockholders |
||||||||||||||||
per common share in euros: |
||||||||||||||||
basic |
0.06 | 0.19 | 1.07 | 0.17 | ||||||||||||
diluted |
0.06 | 0.19 | 1.06 | 0.17 | ||||||||||||
Ratios |
||||||||||||||||
Gross margin as a % of sales |
30.2 | 35.2 | 32.2 | 34.0 | ||||||||||||
Selling expenses as a % of sales |
(20.6 | ) | (22.1 | ) | (19.9 | ) | (22.9 | ) | ||||||||
G&A expenses as a % of sales |
(4.4 | ) | (2.3 | ) | (4.1 | ) | (3.7 | ) | ||||||||
R&D expenses as a % of sales |
(7.0 | ) | (6.6 | ) | (6.7 | ) | (7.3 | ) | ||||||||
EBIT or Income (loss) from operations |
(133 | ) | 237 | 357 | 59 | |||||||||||
as a % of sales |
(2.1 | ) | 4.2 | 1.9 | 0.4 | |||||||||||
EBITA |
57 | 344 | 718 | 388 | ||||||||||||
as a % of sales |
0.9 | 6.1 | 3.8 | 2.4 | ||||||||||||
17
September 28, | December 31, | September 27, | ||||||||||
2008 | 2008 | 2009 | ||||||||||
Current assets: |
||||||||||||
Cash and cash equivalents |
2,460 | 3,620 | 3,734 | |||||||||
Receivables |
5,015 | 4,289 | 4,214 | |||||||||
Inventories |
4,092 | 3,371 | 3,296 | |||||||||
Other current assets |
654 | 749 | 689 | |||||||||
Total current assets |
12,221 | 12,029 | 11,933 | |||||||||
Non-current assets: |
||||||||||||
Investments in equity-accounted investees |
321 | 293 | 270 | |||||||||
Other non-current financial assets |
1,971 | 1,331 | 850 | |||||||||
Non-current receivables |
52 | 47 | 84 | |||||||||
Other non-current assets |
2,849 | 1,906 | 137 | |||||||||
Deferred tax assets |
747 | 931 | 1,368 | |||||||||
Property, plant and equipment |
3,499 | 3,496 | 3,326 | |||||||||
Intangible assets excluding goodwill |
4,591 | 4,477 | 4,165 | |||||||||
Goodwill |
7,321 | 7,280 | 7,242 | |||||||||
Total assets |
33,572 | 31,790 | 29,375 | |||||||||
Current liabilities: |
||||||||||||
Accounts and notes payable |
3,171 | 2,992 | 3,044 | |||||||||
Accrued liabilities |
3,260 | 3,634 | 3,070 | |||||||||
Short-term provisions |
957 | 1,043 | 1,187 | |||||||||
Other current liabilities |
435 | 522 | 628 | |||||||||
Short-term debt |
664 | 722 | 757 | |||||||||
Total current liabilities |
8,487 | 8,913 | 8,686 | |||||||||
Non-current liabilities: |
||||||||||||
Long-term debt |
3,324 | 3,466 | 3,598 | |||||||||
Long-term provisions |
1,809 | 1,794 | 1,747 | |||||||||
Deferred tax liabilities |
904 | 584 | 150 | |||||||||
Other non-current liabilities |
995 | 1,440 | 1,796 | |||||||||
Total liabilities |
15,519 | 16,197 | 15,977 | |||||||||
Minority interests |
53 | 49 | 53 | |||||||||
Stockholders equity |
18,000 | 15,544 | 13,345 | |||||||||
Total liabilities and equity |
33,572 | 31,790 | 29,375 | |||||||||
Number of common shares outstanding (after
deduction of treasury stock) |
||||||||||||
at the end of period (in thousands) |
946,366 | 922,982 | 926,687 | |||||||||
Ratios |
||||||||||||
Stockholders equity per common share in euros |
19.02 | 16.84 | 14.40 | |||||||||
Inventories as a % of sales |
15.1 | 12.8 | 14.0 | |||||||||
Net debt : group equity |
8:92 | 4:96 | 4:96 | |||||||||
Net operating capital |
17,371 | 14,069 | 11,559 | |||||||||
Employees at end of period |
128,011 | 121,398 | 118,225 | |||||||||
18
3rd quarter | January to September | |||||||||||||||
2008 | 2009 | 2008 | 2009 | |||||||||||||
Cash flows from operating activities: |
||||||||||||||||
Net income attributable to stockholders |
57 | 174 | 1,083 | 159 | ||||||||||||
Loss discontinued operations |
(21 | ) | - | (5 | ) | - | ||||||||||
Minority interests |
1 | 2 | 4 | 5 | ||||||||||||
Adjustments to reconcile net income to net cash provided by (used for)
operating activities: |
||||||||||||||||
Depreciation and amortization |
373 | 362 | 994 | 1,040 | ||||||||||||
Impairment of goodwill and (reversal of) impairment of equity-accounted
investees and other non-current financial assets |
309 | (28 | ) | 608 | (4 | ) | ||||||||||
Net gain on sale of assets |
(459 | ) | (3 | ) | (1,569 | ) | (127 | ) | ||||||||
Income from equity-accounted investees |
(7 | ) | (10 | ) | (78 | ) | (11 | ) | ||||||||
Dividends received from equity-accounted investees |
3 | - | 63 | 34 | ||||||||||||
(Increase) decrease in working capital: |
(143 | ) | 194 | (1,334 | ) | 98 | ||||||||||
(Increase) decrease in receivables and other current assets |
(168 | ) | (490 | ) | (412 | ) | 131 | |||||||||
(Increase) decrease in inventories |
(244 | ) | (76 | ) | (684 | ) | 148 | |||||||||
Increase (decrease) in accounts payable, accrued and other liabilities |
269 | 760 | (238 | ) | (181 | ) | ||||||||||
Increase in non-current receivables/other assets/
other liabilities |
(219 | ) | (111 | ) | (252 | ) | (513 | ) | ||||||||
Increase (decrease) in provisions |
339 | (124 | ) | 290 | (99 | ) | ||||||||||
Other items |
(23 | ) | 14 | 83 | 28 | |||||||||||
Net cash provided by (used for) operating activities |
210 | 470 | (113 | ) | 610 | |||||||||||
Cash flows from investing activities: |
||||||||||||||||
Purchase of intangible assets |
(23 | ) | (21 | ) | (87 | ) | (66 | ) | ||||||||
Expenditures on development assets |
(27 | ) | (43 | ) | (137 | ) | (129 | ) | ||||||||
Capital expenditures on property, plant and equipment |
(188 | ) | (121 | ) | (514 | ) | (373 | ) | ||||||||
Proceeds from disposals of property, plant and equipment |
85 | 68 | 157 | 95 | ||||||||||||
Cash from (to) derivatives |
88 | (28 | ) | 343 | (38 | ) | ||||||||||
Purchase of other non-current financial assets |
- | - | - | (6 | ) | |||||||||||
Proceeds from (disposal of) other non-current financial assets |
688 | (8 | ) | 2,576 | 698 | |||||||||||
Purchase of businesses, net of cash acquired |
(26 | ) | (191 | ) | (5,293 | ) | (281 | ) | ||||||||
Proceeds from sale of interests in businesses |
40 | 19 | 40 | 19 | ||||||||||||
Net cash provided by (used for) investing activities |
637 | (325 | ) | (2,915 | ) | (81 | ) | |||||||||
Cash flows from financing activities: |
||||||||||||||||
(Decrease) increase in short-term debt |
(98 | ) | 45 | (96 | ) | (53 | ) | |||||||||
Principal payments on long-term debt |
(9 | ) | (11 | ) | (1,715 | ) | (35 | ) | ||||||||
Proceeds from issuance of long-term debt |
10 | 11 | 2,077 | 300 | ||||||||||||
Treasury stock transactions |
(803 | ) | 6 | (2,886 | ) | 21 | ||||||||||
Dividend paid |
- | - | (698 | ) | (634 | ) | ||||||||||
Net cash used for financing activities |
(900 | ) | 51 | (3,318 | ) | (401 | ) | |||||||||
Net cash used for continuing operations |
(53 | ) | 196 | (6,346 | ) | 128 | ||||||||||
Cash flows from discontinued operations: |
||||||||||||||||
Net cash used for operating activities |
(18 | ) | - | (50 | ) | - | ||||||||||
Net cash used for investing activities |
- | - | (1 | ) | - | |||||||||||
Net cash used for discontinued operations |
(18 | ) | - | (51 | ) | - | ||||||||||
Net cash used for continuing and discontinued
operations |
(71 | ) | 196 | (6,397 | ) | 128 | ||||||||||
Effect of change in exchange rates on cash positions |
41 | (51 | ) | (20 | ) | (14 | ) | |||||||||
Cash and cash equivalents at beginning of period |
2,490 | 3,589 | 8,877 | 3,620 | ||||||||||||
Cash and cash equivalents at end of period |
2,460 | 3,734 | 2,460 | 3,734 | ||||||||||||
Cash of continuing operations at end of period |
2,460 | 3,734 | 2,460 | 3,734 | ||||||||||||
For a number of reasons, principally the effects of translation differences,
certain items in the statements of cash flows do not correspond to the
differences between the balance sheet amounts for the respective items. |
||||||||||||||||
Ratio |
||||||||||||||||
Cash flows before financing activities |
847 | 145 | (3,028 | ) | 529 | |||||||||||
Net cash paid during the period for |
||||||||||||||||
- Pensions |
(90 | ) | (111 | ) | (266 | ) | (315 | ) | ||||||||
- Interest |
(39 | ) | (76 | ) | (117 | ) | (212 | ) | ||||||||
- Income taxes |
(71 | ) | (64 | ) | (279 | ) | (172 | ) |
19
Consolidated statements of changes in equity | ||||||||||||||||||||||||||||||||||||||||||||||||
all amounts in millions of euros | ||||||||||||||||||||||||||||||||||||||||||||||||
January to September 2009 |
||||||||||||||||||||||||||||||||||||||||||||||||
other reserves | ||||||||||||||||||||||||||||||||||||||||||||||||
currency | unrealized gain (loss) | changes in | treasury | total | ||||||||||||||||||||||||||||||||||||||||||||
common | capital in excess | retained | revaluation | translation | on available-for- | fair value of | shares at | stockholders | minority | total | ||||||||||||||||||||||||||||||||||||||
stock | of par value | earnings | reserve | differences | sale securities | cash flow hedges | total | cost | equity | interests | equity | |||||||||||||||||||||||||||||||||||||
Balance as of December 31, 2008 |
194 | - | 17,101 | 117 | (527) | (25) | (28) | (580) | (1,288) | 15,544 | 49 | 15,593 | ||||||||||||||||||||||||||||||||||||
Net income |
159 | - | 159 | 5 | 164 | |||||||||||||||||||||||||||||||||||||||||||
Net current period change |
(1,761) | (11) | (152) | 222 | (27) | 43 | (1,729) | (1) | (1,730) | |||||||||||||||||||||||||||||||||||||||
Reclassifications into (income) loss |
(123) | 71 | (52) | (52) | (52) | |||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income |
(1,602) | (11) | (152) | 99 | 44 | (9) | (1,622) | 4 | (1,618) | |||||||||||||||||||||||||||||||||||||||
Dividend distributed |
(647) | (647) | (647) | |||||||||||||||||||||||||||||||||||||||||||||
Re-issuance of treasury stock |
(49) | (16) | 86 | 21 | 21 | |||||||||||||||||||||||||||||||||||||||||||
Share-based compensation plans |
49 | 49 | 49 | |||||||||||||||||||||||||||||||||||||||||||||
- | (663) | 86 | (577) | (577) | ||||||||||||||||||||||||||||||||||||||||||||
Balance as of
September 27, 2009 |
194 | - | 14,836 | 106 | (679) | 74 | 16 | (589) | (1,202) | 13,345 | 53 | 13,398 |
20
Sales and income (loss) from operations | ||||||||||||||||||||||||
3rd quarter |
||||||||||||||||||||||||
2008 | 2009 | |||||||||||||||||||||||
sales | income from operations | sales | income from operations | |||||||||||||||||||||
amount | as % of | amount | as % of | |||||||||||||||||||||
sales | sales | |||||||||||||||||||||||
Healthcare |
1,806 | 129 | 7.1 | 1,821 | 110 | 6.0 | ||||||||||||||||||
Consumer Lifestyle * |
2,578 | 59 | 2.3 | 2,073 | 126 | 6.1 | ||||||||||||||||||
Lighting |
1,846 | 56 | 3.0 | 1,646 | 40 | 2.4 | ||||||||||||||||||
Group Management & Services |
104 | (377 | ) | (362.5 | ) | 81 | (39 | ) | (48.1 | ) | ||||||||||||||
6,334 | (133 | ) | (2.1 | ) | 5,621 | 237 | 4.2 | |||||||||||||||||
* of which Television |
1,134 | (73 | ) | (6.4 | ) | 767 | (26 | ) | (3.4 | ) | ||||||||||||||
January to September | ||||||||||||||||||||||||
2008 | 2009 | |||||||||||||||||||||||
sales | income from operations | sales | income from operations | |||||||||||||||||||||
amount | as % of | amount | as % of | |||||||||||||||||||||
sales | sales | |||||||||||||||||||||||
Healthcare |
5,080 | 342 | 6.7 | 5,434 | 199 | 3.7 | ||||||||||||||||||
Consumer Lifestyle * |
7,900 | 150 | 1.9 | 5,564 | 61 | 1.1 | ||||||||||||||||||
Lighting |
5,423 | 400 | 7.4 | 4,700 | (57 | ) | (1.2 | ) | ||||||||||||||||
Group Management & Services |
359 | (535 | ) | (149.0 | ) | 228 | (144 | ) | (63.2 | ) | ||||||||||||||
18,762 | 357 | 1.9 | 15,926 | 59 | 0.4 | |||||||||||||||||||
* of which Television |
3,593 | (283 | ) | (7.9 | ) | 2,037 | (208 | ) | (10.2 | ) | ||||||||||||||
21
Sales and total assets | ||||||||||||||||
sales |
total assets | |||||||||||||||
January to September | Sept 28, | Sept 27, | ||||||||||||||
2008 | 2009 | 2008 | 2009 | |||||||||||||
Healthcare |
5,080 | 5,434 | 11,074 | 10,826 | ||||||||||||
Consumer Lifestyle |
7,900 | 5,564 | 4,698 | 3,823 | ||||||||||||
Lighting |
5,423 | 4,700 | 7,915 | 6,874 | ||||||||||||
Group Management & Services |
359 | 228 | 9,885 | 7,852 | ||||||||||||
18,762 | 15,926 | 33,572 | 29,375 | |||||||||||||
|
||||||||||||||||
Sales and long-lived assets | ||||||||||||||||
sales |
long-lived assets * | |||||||||||||||
January to September | Sept 28, | Sept 27, | ||||||||||||||
2008 | 2009 | 2008 | 2009 | |||||||||||||
United States |
5,001 | 4,499 | 10,781 | 9,527 | ||||||||||||
Germany |
1,407 | 1,305 | 310 | 292 | ||||||||||||
China |
1,277 | 1,222 | 233 | 336 | ||||||||||||
France |
1,161 | 977 | 129 | 125 | ||||||||||||
United Kingdom |
767 | 495 | 633 | 580 | ||||||||||||
Netherlands |
713 | 598 | 1,351 | 1,251 | ||||||||||||
Other countries |
8,436 | 6,830 | 1,974 | 2,622 | ||||||||||||
18,762 | 15,926 | 15,411 | 14,733 |
22
Specification of pension costs | ||||||||||||||||||||||||
3rd quarter | ||||||||||||||||||||||||
2008 | 2009 | |||||||||||||||||||||||
Netherlands | other | total | Netherlands | other | total | |||||||||||||||||||
Costs of defined-benefit plans (pensions) |
||||||||||||||||||||||||
Service cost |
33 | 19 | 52 | 26 | 17 | 43 | ||||||||||||||||||
Interest cost on the defined-benefit obligation |
131 | 100 | 231 | 133 | 95 | 228 | ||||||||||||||||||
Expected return on plan assets |
(193 | ) | (98 | ) | (291 | ) | (190 | ) | (83 | ) | (273 | ) | ||||||||||||
Prior service cost |
- | 5 | 5 | - | 1 | 1 | ||||||||||||||||||
Net periodic cost (income) |
(29 | ) | 26 | (3 | ) | (31 | ) | 30 | (1 | ) | ||||||||||||||
Costs of
defined-contribution plans |
||||||||||||||||||||||||
Costs |
3 | 22 | 25 | 3 | 24 | 27 | ||||||||||||||||||
Total |
3 | 22 | 25 | 3 | 24 | 27 | ||||||||||||||||||
Costs of defined-benefit
plans (retiree medical) |
||||||||||||||||||||||||
Service cost |
- | 1 | 1 | - | - | - | ||||||||||||||||||
Interest cost on the defined-benefit obligation |
- | 9 | 9 | - | 9 | 9 | ||||||||||||||||||
Prior service cost |
- | (8 | ) | (8 | ) | - | - | - | ||||||||||||||||
Curtailment |
- | - | - | - | (87 | ) | (87 | ) | ||||||||||||||||
Net periodic cost |
- | 2 | 2 | - | (78 | ) | (78 | ) |
January to September | ||||||||||||||||||||||||
2008 | 2009 | |||||||||||||||||||||||
Netherlands | other | total | Netherlands | other | total | |||||||||||||||||||
Costs of defined-benefit plans (pensions) |
||||||||||||||||||||||||
Service cost |
101 | 63 | 164 | 80 | 61 | 141 | ||||||||||||||||||
Interest cost on the defined-benefit obligation |
393 | 297 | 690 | 399 | 296 | 695 | ||||||||||||||||||
Expected return on plan assets |
(577 | ) | (294 | ) | (871 | ) | (569 | ) | (256 | ) | (825 | ) | ||||||||||||
Prior service cost |
- | 10 | 10 | - | 3 | 3 | ||||||||||||||||||
Net periodic cost (income) |
(83 | ) | 76 | (7 | ) | (90 | ) | 104 | 14 | |||||||||||||||
Costs of defined-contribution plans |
||||||||||||||||||||||||
Costs |
5 | 68 | 73 | 6 | 77 | 83 | ||||||||||||||||||
Total |
5 | 68 | 73 | 6 | 77 | 83 | ||||||||||||||||||
Costs of defined-benefit plans (retiree medical) |
||||||||||||||||||||||||
Service cost |
- | 3 | 3 | - | 1 | 1 | ||||||||||||||||||
Interest cost on the defined-benefit obligation |
- | 26 | 26 | - | 27 | 27 | ||||||||||||||||||
Prior service cost |
- | (6 | ) | (6 | ) | - | - | - | ||||||||||||||||
Curtailment |
- | - | - | - | (87 | ) | (87 | ) | ||||||||||||||||
Net periodic cost |
- | 23 | 23 | - | (59 | ) | (59 | ) |
23
Sales growth composition (in %) | ||||||||||||||||||||||||||||||||
3rd quarter | January to September | |||||||||||||||||||||||||||||||
com- | consol- | com- | consol- | |||||||||||||||||||||||||||||
parable | currency | idation | nominal | parable | currency | idation | nominal | |||||||||||||||||||||||||
growth | effects | changes | growth | growth | effects | changes | growth | |||||||||||||||||||||||||
2009 versus 2008 |
||||||||||||||||||||||||||||||||
Healthcare |
(3.8 | ) | 4.8 | (0.2 | ) | 0.8 | (3.5 | ) | 6.6 | 3.9 | 7.0 | |||||||||||||||||||||
Consumer Lifestyle |
(14.6 | ) | (0.5 | ) | (4.5 | ) | (19.6 | ) | (23.3 | ) | - | (6.3 | ) | (29.6 | ) | |||||||||||||||||
Lighting |
(13.0 | ) | 1.6 | 0.6 | (10.8 | ) | (16.6 | ) | 2.5 | 0.8 | (13.3 | ) | ||||||||||||||||||||
GM&S |
(23.6 | ) | 1.6 | (0.1 | ) | (22.1 | ) | (36.6 | ) | 0.2 | (0.1 | ) | (36.5 | ) | ||||||||||||||||||
Philips Group |
(10.9 | ) | 1.5 | (1.9 | ) | (11.3 | ) | (15.7 | ) | 2.4 | (1.8 | ) | (15.1 | ) |
EBITA to Income from operations (or EBIT) | ||||||||||||||||||||
Philips | Consumer | |||||||||||||||||||
Group | Healthcare | Lifestyle | Lighting | GM&S | ||||||||||||||||
January to September 2009 |
||||||||||||||||||||
EBITA |
388 | 396 | 73 | 63 | (144 | ) | ||||||||||||||
Amortization of intangibles * |
(329 | ) | (197 | ) | (12 | ) | (120 | ) | - | |||||||||||
Income from operations (or EBIT) |
59 | 199 | 61 | (57 | ) | (144 | ) |
January to September 2008 |
||||||||||||||||||||
EBITA |
718 | 496 | 162 | 595 | (535 | ) | ||||||||||||||
Amortization of intangibles * |
(271 | ) | (154 | ) | (12 | ) | (105 | ) | - | |||||||||||
Impairment of goodwill |
(90 | ) | - | - | (90 | ) | - | |||||||||||||
Income from operations (or EBIT) |
357 | 342 | 150 | 400 | (535 | ) |
Composition of net debt and group equity | ||||||||
Sept 28, | Sept 27, | |||||||
2008 | 2009 | |||||||
Long-term debt |
3,324 | 3,598 | ||||||
Short-term debt |
664 | 757 | ||||||
Total debt |
3,988 | 4,355 | ||||||
Cash and cash equivalents |
2,460 | 3,734 | ||||||
Net debt (total debt less cash and cash equivalents) |
1,528 | 621 | ||||||
Minority interests |
53 | 53 | ||||||
Stockholders equity |
18,000 | 13,345 | ||||||
Group equity |
18,053 | 13,398 | ||||||
Net debt and group equity |
19,581 | 14,019 | ||||||
Net debt divided by net debt and group equity (in %) |
8 | 4 | ||||||
Group equity divided by net debt and group
equity (in %) |
92 | 96 | ||||||
24
Net operating capital to total assets | ||||||||||||||||||||
Consumer | ||||||||||||||||||||
Philips Group | Healthcare | Lifestyle | Lighting | GM&S | ||||||||||||||||
September 27, 2009 |
||||||||||||||||||||
Net operating capital (NOC) |
11,559 | 8,413 | 1,041 | 5,382 | (3,277 | ) | ||||||||||||||
Exclude liabilities comprised in NOC: |
||||||||||||||||||||
- payables/liabilities |
8,538 | 1,995 | 2,347 | 1,130 | 3,066 | |||||||||||||||
- intercompany accounts |
- | 33 | 78 | 48 | (159 | ) | ||||||||||||||
- provisions |
2,934 | 312 | 356 | 301 | 1,965 | |||||||||||||||
Include assets not comprised in NOC: |
||||||||||||||||||||
- investments in equity-accounted investees |
270 | 73 | 1 | 13 | 183 | |||||||||||||||
- other current financial assets |
122 | - | - | - | 122 | |||||||||||||||
- other non-current financial assets |
850 | - | - | - | 850 | |||||||||||||||
- deferred tax assets |
1,368 | - | - | - | 1,368 | |||||||||||||||
- liquid assets |
3,734 | - | - | - | 3,734 | |||||||||||||||
Total assets |
29,375 | 10,826 | 3,823 | 6,874 | 7,852 | |||||||||||||||
September 28, 2008 |
||||||||||||||||||||
Net operating capital (NOC) |
17,371 | 8,668 | 1,761 | 6,458 | 484 | |||||||||||||||
Exclude liabilities comprised in NOC: |
||||||||||||||||||||
- payables/liabilities |
7,861 | 2,050 | 2,571 | 1,253 | 1,987 | |||||||||||||||
- intercompany accounts |
- | 40 | 96 | 30 | (166 | ) | ||||||||||||||
- provisions |
2,766 | 259 | 268 | 160 | 2,079 | |||||||||||||||
Include assets not comprised in NOC: |
||||||||||||||||||||
- investments in equity-accounted investees |
321 | 57 | 2 | 14 | 248 | |||||||||||||||
- other current financial assets |
75 | - | - | - | 75 | |||||||||||||||
- other non-current financial assets |
1,971 | - | - | - | 1,971 | |||||||||||||||
- deferred tax assets |
747 | - | - | - | 747 | |||||||||||||||
- liquid assets |
2,460 | - | - | - | 2,460 | |||||||||||||||
Total assets |
33,572 | 11,074 | 4,698 | 7,915 | 9,885 |
Composition of cash flows - continuing operations | ||||||||||||||||
3rd quarter | January to September | |||||||||||||||
2008 | 2009 | 2008 | 2009 | |||||||||||||
Cash flows provided by (used for) operating activities |
210 | 470 | (113 | ) | 610 | |||||||||||
Cash flows provided by (used for) investing activities |
637 | (325 | ) | (2,915 | ) | (81 | ) | |||||||||
Cash flows before financing activities |
847 | 145 | (3,028 | ) | 529 | |||||||||||
Cash flows provided by (used for) operating activities |
210 | 470 | (113 | ) | 610 | |||||||||||
Net capital expenditures |
(153 | ) | (117 | ) | (581 | ) | (473 | ) | ||||||||
Free cash flows |
57 | 353 | (694 | ) | 137 |
25
2008 | 2009 | |||||||||||||||||||||||||||||||
1st | 2nd | 3rd | 4th | 1st | 2nd | 3rd | 4th | |||||||||||||||||||||||||
quarter | quarter | quarter | quarter | quarter | quarter | quarter | quarter | |||||||||||||||||||||||||
Sales |
5,965 | 6,463 | 6,334 | 7,623 | 5,075 | 5,230 | 5,621 | |||||||||||||||||||||||||
% increase |
1 | 7 | (2 | ) | (9 | ) | (15 | ) | (19 | ) | (11 | ) | ||||||||||||||||||||
EBITA |
265 | 396 | 57 | 26 | (74 | ) | 118 | 344 | ||||||||||||||||||||||||
as a % of sales |
4.4 | 6.1 | 0.9 | 0.3 | (1.5 | ) | 2.3 | 6.1 | ||||||||||||||||||||||||
EBIT |
187 | 303 | (133 | ) | (303 | ) | (186 | ) | 8 | 237 | ||||||||||||||||||||||
as a % of sales |
3.1 | 4.7 | (2.1 | ) | (4.0 | ) | (3.7 | ) | 0.2 | 4.2 | ||||||||||||||||||||||
Net income (loss) - stockholders |
294 | 732 | 57 | (1,174 | ) | (59 | ) | 44 | 174 | |||||||||||||||||||||||
per common share in euros |
0.28 | 0.72 | 0.06 | (1.26 | ) | (0.06 | ) | 0.05 | 0.19 | |||||||||||||||||||||||
January- | January- | January- | January- | January- | January- | January- | January- | |||||||||||||||||||||||||
March | June | September | December | March | June | September | December | |||||||||||||||||||||||||
Sales |
5,965 | 12,428 | 18,762 | 26,385 | 5,075 | 10,305 | 15,926 | |||||||||||||||||||||||||
% increase |
1 | 4 | 2 | (2 | ) | (15 | ) | (17 | ) | (15 | ) | |||||||||||||||||||||
EBITA |
265 | 661 | 718 | 744 | (74 | ) | 44 | 388 | ||||||||||||||||||||||||
as a % of sales |
4.4 | 5.3 | 3.8 | 2.8 | (1.5 | ) | 0.4 | 2.4 | ||||||||||||||||||||||||
EBIT |
187 | 490 | 357 | 54 | (186 | ) | (178 | ) | 59 | |||||||||||||||||||||||
as a % of sales |
3.1 | 3.9 | 1.9 | 0.2 | (3.7 | ) | (1.7 | ) | 0.4 | |||||||||||||||||||||||
Net income (loss) - stockholders |
294 | 1,026 | 1,083 | (91 | ) | (59 | ) | (15 | ) | 159 | ||||||||||||||||||||||
per common share in euros |
0.28 | 1.00 | 1.07 | (0.09 | ) | (0.06 | ) | (0.02 | ) | 0.17 | ||||||||||||||||||||||
Net income (loss) from continuing |
||||||||||||||||||||||||||||||||
operations as a % of |
||||||||||||||||||||||||||||||||
stockholders equity (ROE) |
6.2 | 10.8 | 7.8 | (0.5 | ) | (1.7 | ) | (0.2 | ) | 1.5 | ||||||||||||||||||||||
period ended 2008 |
period ended 2009 |
|||||||||||||||||||||||||||||||
Inventories as a % of sales |
13.6 | 13.9 | 15.1 | 12.8 | 13.1 | 13.3 | 14.0 | |||||||||||||||||||||||||
Net debt : group equity ratio |
4:96 | 7:93 | 8:92 | 4:96 | 3:97 | 6:94 | 4:96 | |||||||||||||||||||||||||
Total employees (in thousands) |
134 | 133 | 128 | 121 | 116 | 116 | 118 | |||||||||||||||||||||||||
of which discontinued operations |
6 | 5 | - | - | - | - | - | |||||||||||||||||||||||||
26